FR3056592B1 - Composes pour leur utilisation en imagerie et notamment pour le diagnostic de maladies neuro-degeneratives - Google Patents

Composes pour leur utilisation en imagerie et notamment pour le diagnostic de maladies neuro-degeneratives Download PDF

Info

Publication number
FR3056592B1
FR3056592B1 FR1659033A FR1659033A FR3056592B1 FR 3056592 B1 FR3056592 B1 FR 3056592B1 FR 1659033 A FR1659033 A FR 1659033A FR 1659033 A FR1659033 A FR 1659033A FR 3056592 B1 FR3056592 B1 FR 3056592B1
Authority
FR
France
Prior art keywords
neuro
diagnosis
imaging
compounds
degenerative diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1659033A
Other languages
English (en)
Other versions
FR3056592A1 (fr
Inventor
Sylvain Routier
Franck Suzenet
Sylvie Chalon
Frederic BURON
Johnny Vercouillie
Ronald MELKI
Liliana BOIARYNA
Denis Guilloteau
Laura PIERI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Regional Universitaire de Tours
Universite dOrleans
Universite de Tours
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Francois Rabelais de Tours
Centre Hospitalier Regional Universitaire de Tours
Universite dOrleans
Universite de Tours
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Universite Francois Rabelais de Tours, Centre Hospitalier Regional Universitaire de Tours, Universite dOrleans, Universite de Tours filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1659033A priority Critical patent/FR3056592B1/fr
Priority to US16/336,309 priority patent/US10906900B2/en
Priority to PCT/FR2017/052592 priority patent/WO2018055316A1/fr
Priority to EP17783941.2A priority patent/EP3515912B1/fr
Publication of FR3056592A1 publication Critical patent/FR3056592A1/fr
Application granted granted Critical
Publication of FR3056592B1 publication Critical patent/FR3056592B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
FR1659033A 2016-09-26 2016-09-26 Composes pour leur utilisation en imagerie et notamment pour le diagnostic de maladies neuro-degeneratives Expired - Fee Related FR3056592B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1659033A FR3056592B1 (fr) 2016-09-26 2016-09-26 Composes pour leur utilisation en imagerie et notamment pour le diagnostic de maladies neuro-degeneratives
US16/336,309 US10906900B2 (en) 2016-09-26 2017-09-26 Compounds for using in imaging and particularly for the diagnosis of neurodegenerative diseases
PCT/FR2017/052592 WO2018055316A1 (fr) 2016-09-26 2017-09-26 Composes pour leur utilisation en imagerie et notamment pour le diagnostic de maladies neuro-degeneratives
EP17783941.2A EP3515912B1 (fr) 2016-09-26 2017-09-26 Composes pour leur utilisation en imagerie et notamment pour le diagnostic de maladies neuro-degeneratives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1659033 2016-09-26
FR1659033A FR3056592B1 (fr) 2016-09-26 2016-09-26 Composes pour leur utilisation en imagerie et notamment pour le diagnostic de maladies neuro-degeneratives

Publications (2)

Publication Number Publication Date
FR3056592A1 FR3056592A1 (fr) 2018-03-30
FR3056592B1 true FR3056592B1 (fr) 2018-11-16

Family

ID=57396670

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1659033A Expired - Fee Related FR3056592B1 (fr) 2016-09-26 2016-09-26 Composes pour leur utilisation en imagerie et notamment pour le diagnostic de maladies neuro-degeneratives

Country Status (1)

Country Link
FR (1) FR3056592B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691187B2 (en) * 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
EP2411057B1 (fr) * 2009-03-23 2020-05-06 Eli Lilly and Company Agents d'imagerie pour détecter des troubles neurologiques

Also Published As

Publication number Publication date
FR3056592A1 (fr) 2018-03-30

Similar Documents

Publication Publication Date Title
FR24C1001I1 (fr) Anticorps anti-pd1 et leur utilisation en tant qu'agents thérapeutiques et de diagnostic
MA44776A (fr) Anticorps anti-vista humain et leur utilisation
MA45481A (fr) Utilisation d'exosomes pour le traitement de maladies
ES2968132T3 (es) Preparación farmacéutica de palbociclib y uso médico de la misma
EP3337465A4 (fr) Compositions et méthodes d'utilisation en association destinées au traitement et au diagnostic de maladies auto-immunes
EP3408349A4 (fr) Sondes chimioluminescentes destinées au diagnostic et à l'imageriein vivo
MA43980A (fr) Méthodes de diagnostic et de pronostic de maladies et d'événements cardiovasculaires
IL262354A (en) Ultrasound treatment and imaging device
KR102209382B9 (ko) 병변 진단에 대한 정보 제공 방법 및 이를 이용한 병변 진단에 대한 정보 제공용 디바이스
MA49368A (fr) Imidazopyrimidines à substitution diazabicyclique et leur utilisation pour traiter des maladies des voies respiratoires
WO2015031815A3 (fr) Anticorps et dosages pour la détection du récepteur 1 du folate
EP3166688A4 (fr) Ligands de visualisation de tau et leurs utilisations dans le diagnostic et le traitement de tauopathies
EP3534969A4 (fr) Formulations pour radiothérapie et imagerie diagnostique
EP3111849A4 (fr) Sonde ultrasonore et dispositif d'imagerie ultrasonore l'utilisant
EP3123176A4 (fr) Diagnostic de la sclérose en plaques chez des sujets humains et animaux
IL247368A0 (en) Diagnostic and therapeutic uses of exosomes
GB201809841D0 (en) Ultrasound imaging probe
HK1248304A1 (zh) 使用吸收性成像計量學測量眼科鏡片厚度的系統和方法
ZA201806418B (en) Methods and compositions for the detection and diagnosis of renal disease and periodontal disease
PL3377909T3 (pl) Laktoferyna do zastosowania w diagnozowaniu lub prognozowaniu choroby Alzheimera
EP3534147A4 (fr) Dispositif d'imagerie tomographique par cohérence optique et procédé de mesure
IL277148A (en) Thumb-dominant ultrasound imaging system
MA52644A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
EP3409208A4 (fr) Sonde ultrasonore et système de diagnostic ultrasonore la comprenant
LT3787576T (lt) Viso kūno hipertermijos sistema

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180330

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20230505